Blue Phosphorescent Imidazophenanthridine OLED Materials
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current OLED technologies face challenges in achieving long-lived blue phosphorescent devices with high efficiency, as existing blue-emissive phosphorescent dopants have short lifetimes, failing to meet the requirement of over 10,000 hours at 200 nits initial luminescence.
Innovation Solution
Development of new classes of phosphorescent metal complexes utilizing cyclometallated imidazo[1,2-f]phenanthridine or diimidazo[1,2-a:1′,2′-c]quinazoline ligands, which exhibit narrow phosphorescent emission lineshapes and high triplet energies, incorporated into OLED devices to enhance lifetime and efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing blue-emissive phosphorescent dopants are used in OLED devices, then the devices can be fabricated with current technology, but the device lifetime is short and fails to meet the requirement of over 10,000 hours at 200 nits initial luminescence
Solution Approach 1:
The patent changes the chemical structure parameters of the phosphorescent dopants by developing new classes of cyclometallated iridium complexes with imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1′,2′-c]quinazoline ligands. These structural modifications result in materials with high triplet energies and narrow emission lineshapes, enabling device lifetimes exceeding 10,000 hours at 200 nits initial luminescence while maintaining blue emission characteristics.
2Duration of action of stationary object
If new phosphorescent metal complexes with improved lifetime are developed, then device lifetime exceeds 10,000 hours, but the complexity of material synthesis and characterization increases
Solution Approach 1:
The patent segments the development process into distinct stages: (1) synthesis of ligand precursors, (2) cyclometallation reactions to form the iridium complexes, and (3) device fabrication. This segmentation allows each stage to be optimized independently, with established synthetic routes for the ligands and standardized device processing, thereby managing overall complexity despite the novelty of the materials.
3Productivity
If phosphorescent dopants with narrow emission lineshapes and high triplet energies are used, then external quantum efficiency is improved, but the difficulty of synthesizing these specific molecular structures increases
Solution Approach 1:
The patent develops a universal platform of cyclometallated iridium complexes where the core imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1′,2′-c]quinazoline ligand frameworks can be systematically modified with various substituents. This universal structure provides high triplet energies and narrow emission lineshapes across the entire series, enabling efficient blue, green, and red emission while using a common synthetic approach that simplifies manufacturing compared to developing entirely new molecular architectures for each emission color.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new complexes demonstrate significantly improved lifetimes and external quantum efficiency, with some devices achieving over 10,000 hours at 200 nits initial luminescence, addressing the shortcoming of existing blue phosphorescent OLEDs.
Implementation Method 1
OLEDs make use of thin organic films that emit light when voltage is applied across the device... phosphorescent metal complexes... exhibit narrow phosphorescent emission lineshapes and high triplet energies
Data Source
AI summary
Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1′,2′-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting devices comprising these compounds are also described.